tag disease-awareness 
Pharmaceutical Technology
JULY 14, 2022
It is estimated that there are currently more than 7,000 orphan diseases, many of which are considered life-threatening and most of which have a genetic basis. Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union. Go-to-market strategies.
XTalks
FEBRUARY 8, 2024
Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
OCTOBER 11, 2023
Murray, PhD NIH Associate Director for Prevention and Director, NIH Office of Disease Prevention Moderator: Jonathan C. Moyer, PhD Statistician, NIH Office of Disease Prevention Slides Keywords Implementation; Study design; Hybrid; Clustered; DECIPHeR Key Points People often contest that hybrid designs are not as rigorous as they should be.
Rethinking Clinical Trials
OCTOBER 26, 2023
show that a cure is not sufficient to guarantee disease elimination. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. The initiative would bring to the U.S.
XTalks
AUGUST 25, 2021
And while the Centers for Disease Control and Prevention (CDC) maintains that, “there is no evidence to support transmission of COVID-19 associated with food,” samples were still largely nixed as a precautionary measure. But without food sampling, consumers may not be able to justify the $6 price tag, let alone be aware of the brand. .
Intouch Solutions
JULY 27, 2021
American politicians have been aware of, and looking for solutions to, drug pricing and affordability issues for literally decades. they pointed out that the COVID-19 vaccines, and the controversial approval of aducanumab for the treatment of Alzheimer’s disease, represented polar opposites in terms of drug pricing reform.
Rethinking Clinical Trials
SEPTEMBER 22, 2022
The DECODE trial used registry data to identify patients with chronic kidney disease. What was the type of engagement; were people aware clinicians were involved? Discussion Themes. -I I was struck by the number of people that were approached and joined the DANFLU study. For most trials it’s 2-4%. Learn more. Read about DANFLU-1.
Expert insights. Personalized for you.
147 
Let's personalize your content